Statistics: Egyptian Rheumatology & Rehabilitation
Geo Map
Region
#
EU - Europe
16
NA - North America
14
AF - Africa
4
AS - Asia, other
4
Unknown
112
Total
150
Country
#
FI - Finland
10
US - United States of America
10
DE - Germany
5
CA - Canada
4
EG - Egypt
4
CN - China
3
IR - Iran
1
RU - Russian Federation
1
Unknown
112
Total
150
City
#
Jacksonville
4
Toronto
4
Cairo
3
Mountain View
3
West Chester
3
Gîza
1
Nanjing
1
Tabriz
1
Wuhan
1
Unknown
129
Total
150
Most viewed items
#
ID: 2909 - Evaluation of disease activity markers in relation to dry eye disease in patients with rheumatoid arthritis
32
Total
32
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2019
0 0
0 0 0 0
4 5 0 0
2 4
15
2020
6 0
4 0 0 0
0 4 0 0
0 1
15
2021
0 0
0 0 0 4
0 0 0 4
1 1
10
2022
4 0
0 0 1 0
1 3 0 26
2 4
41
2023
0 1
1 6 3 0
0 0 3 4
1 1
20
2024
1 3
12 6 1 1
3 0 0 0
0 0
27
Ever
150
Geo Map
Region | # |
---|---|
EU - Europe | 16 |
NA - North America | 14 |
AF - Africa | 4 |
AS - Asia, other | 4 |
Unknown | 112 |
Total | 150 |
Country | # |
---|---|
FI - Finland | 10 |
US - United States of America | 10 |
DE - Germany | 5 |
CA - Canada | 4 |
EG - Egypt | 4 |
CN - China | 3 |
IR - Iran | 1 |
RU - Russian Federation | 1 |
Unknown | 112 |
Total | 150 |
City | # |
---|---|
Jacksonville | 4 |
Toronto | 4 |
Cairo | 3 |
Mountain View | 3 |
West Chester | 3 |
Gîza | 1 |
Nanjing | 1 |
Tabriz | 1 |
Wuhan | 1 |
Unknown | 129 |
Total | 150 |
Most viewed items | # |
---|---|
ID: 2909 - Evaluation of disease activity markers in relation to dry eye disease in patients with rheumatoid arthritis | 32 |
Total | 32 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 5 | 0 | 0 | 2 | 4 | 15 |
2020 | 6 | 0 | 4 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 1 | 15 |
2021 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 4 | 1 | 1 | 10 |
2022 | 4 | 0 | 0 | 0 | 1 | 0 | 1 | 3 | 0 | 26 | 2 | 4 | 41 |
2023 | 0 | 1 | 1 | 6 | 3 | 0 | 0 | 0 | 3 | 4 | 1 | 1 | 20 |
2024 | 1 | 3 | 12 | 6 | 1 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 27 |
Ever | 150 |